Table 3 Formation of homo- and heterodimers; energies in kcal mol−1
a
b
c
Entry
Mixture
Homodimer RGtotal
Heterodimer RGtotal
DGtotal
−TDS
I
II
III
IV
V
1·3
2·4
1·2
3·4
1·4
3·2
−150.3
−63.3
−185.5
−28.0
−106.7
−106.9
−152.0
−61.1
−188.5
−27.0
−107.0
−105.4
−1.7
2.2
−3.0
1.0
−0.3
1.5
0.4
1.0
−0.6
−1.9
−2.0
−1.3
VI
a Calculated as sum of Gtotal of the two homodimers. b Two times Gtotal of the heterodimer. c Column 4 − column 3.
switches from hetero- to homodimers when going from CD2Cl2
to CDCl3. Obviously these subtle effects are also the reasons why
no significant conclusions can be drawn from MD-simulations.
6.74 (1H, d, J 2.4, ArH), 4.92 (2H, d, J 11.6, ArCH2Ar), 4.36
(2H, d, J 11.6, ArCH2Ar), 4.23–3.98 (12H, m, OCH2), 3.67–3.63
(4H, m, OCH2), 3.17 (2H, d, J 11.6, ArCH2Ar), 3.12 (2H, d, J
11.6, ArCH2Ar), 2.48 (6H, s, CH3), 2.47 (6H, s, CH3); m/z (ESI)
1435.5 (M+Na, 100%).
Experimental
All solvents were of analytical quality (p. a.) and were used
without additional purification. The melting points were
uncorrected. All solvents for NMR were purchased from
Self-assembly studies
In a typical experiment tetraurea calix[4]arenes 1 (5.55 mg,
4.32 lmol) and 2 (6.68 mg, 4.32 lmol) were mixed together,
dichlormethane-d2 (0.7 mL) was added and the solution formed
(sometimes with the help of an ultrasonic bath) was transferred
in an NMR tube and 1H NMR spectra were recorded.
1
Deutero GmbH. H NMR were recorded on a Bruker Avance
DRX 400 or a Bruker AC200 instrument at 400 or 200 MHz.
13C NMR spectra were recorded on a Bruker Avance DRX
400 at 100 MHz. The solvent signals were used for calibration
of NMR spectra. Starting tetraamino tetrapentoxy 513 and
tetraamino biscrown 614 calix[4]arenes were synthesized in
accordance with the published procedures.
1
Heterodimers 1·4, 2·3 and 3·4 were prepared analogously. H
NMR spectra of the heterodimers are given below.
1·2 dH (400 MHz, CD2Cl2) NH: 10.81 (4H, s), 8.04 (4H, s),
7.96 (4H, s), 6.91 (4H, br s); ArHTos: 8.14 (8H, d, J 8.2), 7.48
(8H, d, J 8.2); ArHTol: 7.60 (8H, d, J 7.7), 6.87 (8H, d, J 7.7);
ArHcal: 7.88 (4H, s), 7.01 (4H, s), 6.96 (4H, s), 4.86 (4H, s);
ArCH2Ar: 4.58 (4H, d, J 11.7), next 4H are overlapped with
multiplet at 4.00–3.89, 3.33 (4H, d, J 11.7), 2.59 (4H, d, J 11.7);
OCH2: 4.00–3.89 (12H (from them 4H belong to ArCH2Ar), m),
3.60–3.45 (8H, m); CH3Tos: 2.50 (12H, s); CH3Tol: 2.08 (12H, s);
CH2: 1.83–1.72 (8H, m), 1.60–1.19 (40H, m); CH3alk: 0.99 (12H,
t, J 7.2), 0.90 (12H, t, J 7.2).
1·2 dH (400 MHz, CDCl3) NH: 10.52 (4H, s), 8.04 (4H, s), 8.02
(4H, s), 7.62 (4H, s); ArHTos: 8.14 (8H, d, J 8.2), 7.48 (8H, d, J
8.2); ArHTol: 7.57 (8H, d, J 8.3), 6.79 (8H, d, J 8.3); ArHcal: 7.86
(4H, d, J 2.3), 7.04 (4H, d, J 2.3), 6.87 (4H, d, J 2.3), (4H, d, J
2.3); ArCH2Ar: 4.54 (4H, d, J 11.7), 3.91 (4H, d, J 11.7), 3.37
(4H, d, J 11.7), 2.52 (4H, d, J 11.7); OCH2: 3.95–3.84 (8H, m),
3.53–3.40 (8H, m); CH3Tos: 2.48 (12H, s); CH3Tol: 2.05 (12H, s);
CH2: 1.72–1.68 (8H, m), 1.45–1.12 (40H, m); CH3alk: 0.97 (12H,
t, J 7.0), 0.88 (12H, t, J 7.0).
1·4 dH (400 MHz, CD2Cl2) NH: 10.91 (2H, br s), 10.68 (2H,
br s), 8.09 (4H, s), 7.99 (2H, s), 7.96 (2H, s), 7.09 (2H, br s),
6.95–6.90 (2H, br s); ArHTos: 8.14 (8H, d, J 8.3), 7.48 (8H, d, J
8.3); ArHTol: 7.64 (4H, d, J 8.3), 7.61 (4H, d, J 8.3), 6.93 (4H,
d, J 8.3), 6.90 (4H, d, J 8.3); ArHcal: 7.91 (2H, d, J 1.9), 7.88
(2H, d, J 1.9), 7.16 (2H, s), 7.02 (2H, d, J 1.9), 6.99 (4H, s), 4.96
(2H, s), 4.93 (2H, d, J 1.9); ArCH2Ar: 4.60 (2H, d, J 11.7), 4.59
(2H, d, J 11.7), 4.51 (2H, d, J 11.7), next 2H are overlapped
with multiplet at 4.12–3.82, 3.35 (2H, d, J 11.7), 3.34 (2H, d, J
11.7), 2.64 (2H, d, J 11.7), 2.57 (2H, d, J 11.7); OCH2: 4.12–3.82
(22H (from them 2H belong to ArCH2Ar), m), 3.48–3.40 (4H,
m); CH3Tos: 2.51 (12H, s); CH3Tol: 2.12 (12H, s); CH2: 1.51–1.40
(24H, m); CH3alk: 1.02–0.98 (12H, m).
1·4 dH (400 MHz, CDCl3) NH: 10.54 (2H, s), 10.29 (2H, s),
8.08 (2H, s), 8.06 (2H, s), 8.05 (2H, s), 8.00 (2H, s), 7.84 (2H,
s), 7.76 (2H, s); ArHTos: 8.13 (8H, d, J 8.3), 7.41 (8H, d, J 8.3);
ArHTol: 7.59 (4H, d, J 8.3), 7.56 (4H, d, J 8.3), 6.83 (4H, d, J
8.3), 6.81 (4H, d, J 8.3); ArHcal: 7.86 (4H, s), 7.04 (4H, s), 7.00
(2H, s), 6.90 (2H, s), 5.04 (2H, s), 4.92 (2H, s); ArCH2Ar: 4.55
(2H, d, J 11.7), 4.54 (2H, d, J 11.7), 4.42 (2H, d, J 11.7), next 2H
are overlapped with multiplet at 4.12–3.78, 3.37 (2H, d, J 11.7),
3.36 (2H, d, J 11.7), 2.57 (2H, d, J 11.7), 2.52 (2H, d, J 11.7);
OCH2: 4.12–3.78 (22H (from them 2H belong to ArCH2Ar), m),
3.48–3.42 (4H, m); CH3Tos: 2.46 (12H, s); CH3Tol: 2.06 (12H, s);
CH2: 1.50–1.36 (24H, m); CH3alk: 1.01–0.96 (12H, m).
5,11,17,23-Tetratosylurea-25,26,27,28-tetrapentoxycalix[4]-
arene 2
The tetraamine 5 (0.50 g, 0.65 mmol) was dissolved in CH2Cl2
(10 ml) and tosyl isocyanate (0.77 g (0.60 ml), 3.92 mmol) was
added to the solution. The reaction mixture was stirred overnight
at room temperature and then MeOH (20 ml) was added. The
precipitate was filtered, washed with MeOH (3 × 10 ml) and
dried, yielding a white powder (0.65 g, 77%); mp 216 °C; dH
(400 MHz; DMSO-d6) 10.17 (4H, s, NH), 8.42 (4H, s, NH), 7.79
(8H, d, J 7.8, ArHTos), 7.42 (8H, d, J 7.8, ArHTos), 6.60 (8H, s,
ArH), 4.20 (4H, d, J 12.5, ArCH2Ar), 3.71 (8H, t, J 7.0, OCH2),
3.01 (4H, d, J 12.5, ArCH2Ar), 2.40 (12H, s, CH3Tos), 1.80 (8H,
br s, CH2), 1.31 (16H, br s, CH2), 0.87 (12H, t, J 6.4, CH3); dH
(400 MHz, CD2Cl2) 10.11 (4H, s, NH), 7.95 (12H, m, ArH,
ArHTos), 7.76 (4H, s, NH), 7.39 (8H, d, J 7.8, ArHTos), 6.67 (4H,
s, ArH), 4.34 (4H, d, J 11.7, ArCH2Ar), 3.71 (8H, br s, OCH2),
4.34 (4H, d, J 11.7, ArCH2Ar), 2.41 (12H, s, CH3Tos), 1.90 (8H,
br s, CH2), 1.32–1.20 (16H, m, CH2), 0.87 (12H, t, J 6.8, CH3);
m/z (ESI) 1575.7 (M+Na, 100%).
5,11,17,23-Tetratosylurea-25,26-27,28-biscrown-3-calix[4]-arene 4
Tetraamine 6 (0.34 g, 0.54 mmol) was dissolved in a mixture
of THF–CHCl3 = 1:1 (50 ml) and tosyl isocyanate (1.28 g
(0.99 ml), 6.53 mmol) was added to the solution. The reaction
mixture was stirred overnight at room temperature. The solvent
was removed at reduced pressure and Et2O (30 ml) was added.
The crude product was filtered, washed with Et2O (3 × 15 ml),
MeOH (5 ml), precipitated from a CHCl3–MeOH mixture and
dried yielding a light yellow powder (0.35 g, 46%); mp > 206 °C
decomp.; dH (200 MHz; DMSO-d6) 10.47 (4H, br s, NH), 8.44
(4H, s, NH), 7.82 (8H, d, J 7.80, ArHTos), 7.41 (8H, d, J 7.80,
ArHTos), 6.90 (8H, s, ArH), 4.80 (2H, d, J 12.2, ArCH2Ar),
4.31–4.12 (14H, m, ArCH2Ar, OCH2), 3.61–3.35 (4H, m,
OCH2), 3.15–3.12 (2H, d, J 12.2, ArCH2Ar), 2.39 (12H, s, CH3);
dH (400 MHz, CD2Cl2) 10.20 (4H, br s, NH), 8.24 (1H, s, NH),
8.19 (1H, s, NH), 8.13 (1H, s, NH), 8.07 (1H, s, NH), 8.02 (4H,
d, J 8.2, ArHTos), 8.01 (4H, d, J 8.2, ArHTos), 7.97 (1H, d, J 2.4,
ArH), 7.95 (1H, d, J 2.4, ArH), 7.85 (1H, d, J 2.4, ArH), 7.83
(1H, d, J 2.4, ArH), 7.46 (8H, d, J 8.2, ArHTos), 6.82 (1H, d, J
2.4, ArH), 6.80 (1H, d, J 2.4, ArH), 6.75 (1H, d, J 2.4, ArH),
O r g . B i o m o l . C h e m . , 2 0 0 4 , 2 , 3 0 8 0 – 3 0 8 4
3 0 8 3